There’s more money sloshing around in biotech than ever before.
Over the past year, several trends have converged to create a historic financing environment for startups, full of what industry insiders call “dry powder.”
Continue to STAT+ to read the full story…
STAT+: Biotech venture capitalists have more money than ever to invest. What could possibly go wrong?